Bridgeway Capital Management »

Candel Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $500k 81k 6.20
2024-03-31 $131k 83k 1.58
2023-09-30 $123k 133k 0.93
2023-06-30 $167k 133k 1.26
2023-03-31 $182k 133k 1.37
2022-12-31 $238k 133k 1.79
2022-09-30 $417k 133k 3.14
2022-06-30 $430k 133k 3.24
2022-03-31 $382k 75k 5.09